Royal Society

Lingyun Xiang was awarded the King's Leadership Award and was awarded the King Charles III Medal of the United Kingdom

Retrieved on: 
木曜日, 5月 9, 2024
FAIA, Royal Society, School, Society, Institute of Public Accountants, United Nations, British national identity, IPA, Republic, FCPA, Royal charter, Majesty, IAAP, Peking University, Medal, Royal, FFA, Natural science, FIPA, National university, Nightclub

RSSG was founded in 1894 with the aim of promoting "Britishness" and the British way of life.

Key Points: 
  • RSSG was founded in 1894 with the aim of promoting "Britishness" and the British way of life.
  • The Society soon attracted the support of many prominent public figures in Britain.
  • Queen Victoria was the Society's first royal patron, and since then, RSSG has enjoyed the patronage of every reigning monarch.
  • Said Lingyun Xiang, a member of the RSSG and a recipient of the King's Medal of the Order of the United Kingdom.

ORYZON to Provide Corporate Progress Updates at Several Events in May

Retrieved on: 
木曜日, 5月 9, 2024
Royal Society, Drug, LSD1, Foro, Royal, Genomics

Oryzon will attend Bio-Equity Europe 2024, which will be held at the Kursaal Elkargunea Center in San Sebastián (Spain) on May 12-14.

Key Points: 
  • Oryzon will attend Bio-Equity Europe 2024, which will be held at the Kursaal Elkargunea Center in San Sebastián (Spain) on May 12-14.
  • The company will provide a corporate update on May 13 at 15:15 CET and will hold one-on-one meetings with global investors and pharmaceutical companies.
  • Oryzon will participate in a panel entitled “Alternative secondary markets.
  • Click on the link for more info about Foro Medcap 2024

Pfizer Announces New Chief Strategy and Innovation Officer

Retrieved on: 
月曜日, 5月 6, 2024
Oncology, Health, Infectious Diseases, Research, Science, Pharmaceutical, Biotechnology, Royal Society, University of Oxford, Morgan Stanley, Medical tourism, Vaccine, Patient, PFE, Bachelor, Cancer, Inc., Growth, Head, Pharmaceutical industry

Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President.

Key Points: 
  • Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President.
  • Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla.
  • Dr. Baum will begin his role at Pfizer on June 3, 2024, succeeding Aamir Malik, who recently moved into a new role at Pfizer as Chief U.S. Commercial Officer, Executive Vice President.
  • "I am thrilled to be joining Pfizer as Chief Strategy and Innovation Officer.

Visionary transitions from education to innovative technology, life sciences, and AI education

Retrieved on: 
水曜日, 5月 8, 2024
Education, GV, Royal Society, University, Nicotinamide mononucleotide, Guoli, News, AI, Happiness, Senate, Artificial intelligence, Federation, Science, NMN, Acquisition, Parliament, Royal, Beauty, Drug development, Nicotinamide, Longevity, The Company, Technical, Management

They commended Visionary for its positive contributions to advancing science, technology, and education in Canada.

Key Points: 
  • They commended Visionary for its positive contributions to advancing science, technology, and education in Canada.
  • They believe that Visionary will continue to provide more opportunities and contributions to the advancement of technology and innovation economy in Canada.
  • Faced with significant changes in Canadian education policies, which notably restricted international student visas and reshaped the education system, Visionary initiated a strategic transformation in September 2023.
  • Transitioning from traditional education to high technology, life sciences, and AI education, after over six months of efforts, we have successfully executed this strategic transformation objectives.

Six recipients from across Canada recognized for their ground-breaking work and excellence in Innovation - Governor General's Innovation Awards

Retrieved on: 
火曜日, 4月 30, 2024
Royal Society of Canada, Royal Society, Rideau Hall, Bowhead whale, Rideau Hall Foundation, Ecosystem, Cardiac surgery, Disability, Research, Bacteria, Moral development, Cleveland Clinic, Innovation, Health Canada, The Economist, Artificial intelligence, Carbon, Digital economy, Reach, Humanities, Entrepreneurship, Future, Behavior, RHF, Survivor, Journalism, Food, University, Social science, Committee, Universities Canada, Diagnosis, Government, Quality of life, Graves (surname), Organization, Nursing

OTTAWA, ON, April 30, 2024 /CNW/ - Today the Rideau Hall Foundation (RHF) announced the recipients of the ninth annual Governor General's Innovation Awards (GGIA).

Key Points: 
  • OTTAWA, ON, April 30, 2024 /CNW/ - Today the Rideau Hall Foundation (RHF) announced the recipients of the ninth annual Governor General's Innovation Awards (GGIA).
  • These awards recognize and celebrate exceptional Canadian individuals, teams and organizations for their excellence in innovation and their contributions in helping to shape our future and positively impact our quality of life.
  • The recipients of the 2024 Governor General's Innovation Awards are:
    Following a snowboarding accident, Christian Bagg recognized the limitations of existing assistive technology for people with disabilities.
  • Inneo is a revolution in the food world, being the first bacteriocin approved by Health Canada to eliminate bacteria from food.

Fraser Institute News Release: No evidence of increasing droughts, floods, hurricanes and wildfires, despite activist claims

Retrieved on: 
木曜日, 4月 18, 2024
Royal Society, Bangladesh Technical Education Board, Flood, Weather, Fire, Research, Fraser Institute, Extreme weather, Wildfire, Public policy, Climate change, Journal, Climate action, Drought, Green, Coal

Flooding: Research in the Journal of Hydrology in 2017, analyzing 9,213 recording stations around the world, found there were more stations exhibiting significant decreasing trends (in flood risk) than increasing trends.

Key Points: 
  • Flooding: Research in the Journal of Hydrology in 2017, analyzing 9,213 recording stations around the world, found there were more stations exhibiting significant decreasing trends (in flood risk) than increasing trends.
  • Hurricanes: Research conducted for the World Meteorological Organization in 2019 (updated in 2023) found no long-term trends in hurricanes or major hurricanes recorded globally going back to 1980.
  • “The evidence is clear—many of the claims that extreme weather events are increasing are simply not empirically true,” Green said.
  • “Before governments impose new regulations or enact new programs, they need to study the actual data and base their actions on facts, not unsubstantiated claims.”

New RSC Policy Briefing: “Health Research System Recovery: Strengthening Canada’s Health Research System After the COVID-19 Pandemic”

Retrieved on: 
木曜日, 4月 11, 2024
Royal Society, Task force, University, Working Group, FRSC, Policy, Health, RSC, University of Toronto, Peer review, Research, Science, Trust, Working group, Royal, COVID-19, Pharmaceutical industry

Ottawa, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- The RSC has released its latest report titled “ Health Research System Recovery: Strengthening Canada’s Health Research System After the COVID-19 Pandemic ."

Key Points: 
  • Ottawa, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- The RSC has released its latest report titled “ Health Research System Recovery: Strengthening Canada’s Health Research System After the COVID-19 Pandemic ."
  • The report goes beyond preparing for the next pandemic or health emergency by outlining how to comprehensively reshape Canada’s health research system.
  • Co-Chair of the Working Group, Dr. Sharon Straus, FRSC, University of Toronto, said: “We have a chance to reshape and advance Canada’s health research system to strengthen our health systems, embed health in all policy, rebuild trust in science and improve health.
  • With input from members of the public, funders, researchers, research institution leaders, and policy and decision makers, we developed 12 actionable recommendations.

Yili Innovation Center Europe Kicks Off All-round Upgrades

Retrieved on: 
月曜日, 4月 22, 2024
Science, CDIA, Royal Society, Food safety, University, Nature, Cheese, Yili Group, IDF, Diplomatic mission, International Life Sciences Institute, Wageningen University & Research, AI, Innovation system, Breast milk, Nobel Prize, Partnership, Research, Wendy Larner, Food, Springer Nature, Wageningen, University of Cambridge

At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.

Key Points: 
  • At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.
  • At the site, YICE released ten major innovation achievements, covering areas such as breast milk research, probioticsdevelopment, cheese innovation, sugar reduction, food safety, and the development and application of AI technology products.
  • I'm looking forward to continuing this collaboration with Yili with its open spirit for collaboration with colleagues, academics, and their drive for innovation. "
  • The latest scientific research achievements of the European Center of the National Center of Technology Innovation for Dairy also made their debut at the event site.

Yili Innovation Center Europe Kicks Off All-round Upgrades

Retrieved on: 
月曜日, 4月 22, 2024
Science, CDIA, Royal Society, Food safety, University, Nature, Cheese, Yili Group, IDF, Diplomatic mission, International Life Sciences Institute, Wageningen University & Research, AI, Innovation system, Breast milk, Nobel Prize, Partnership, Research, Wendy Larner, Food, Springer Nature, Wageningen, Multimedia, University of Cambridge

At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.

Key Points: 
  • At the ceremony, Liu Chunxi, Executive President of Yili Group, introduced how the Group collaborated with partners from upstream and downstream segments in global industrial supply chains for years to strive for innovation.
  • At the site, YICE released ten major innovation achievements, covering areas such as breast milk research, probioticsdevelopment, cheese innovation, sugar reduction, food safety, and the development and application of AI technology products.
  • I'm looking forward to continuing this collaboration with Yili with its open spirit for collaboration with colleagues, academics, and their drive for innovation. "
  • The latest scientific research achievements of the European Center of the National Center of Technology Innovation for Dairy also made their debut at the event site.

OMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmann

Retrieved on: 
月曜日, 4月 8, 2024
Royal, Medicine, FRS, Biochemical Society, Translational research, Wellcome Sanger Institute, Woman, Drug discovery, Trinity College, Royal Society, International, GSK, University, Membrane, Patient, Doctor of Philosophy, EMBO Gold Medal, University College London, Translation, Architecture, Therapy, Immune system, SAB, The Genetics Society, Molecular biology, Pharmaceutical industry

Oxford, United Kingdom – 8th April 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Sarah Teichmann PhD, FMedSci, FRS to its Scientific Advisory Board (SAB), effective immediately.

Key Points: 
  • Oxford, United Kingdom – 8th April 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Sarah Teichmann PhD, FMedSci, FRS to its Scientific Advisory Board (SAB), effective immediately.
  • During this time, she also collaborated with OMass’ co-founder, Professor Dame Carol Robinson, on unraveling the in vivo and in vitro assembly of soluble protein complexes.
  • Ali Jazayeri, Chief Scientific Officer at OMass Therapeutics, commented: “I look forward to working with Sarah.
  • Our previous long-standing collaboration on the assembly of soluble protein complexes demonstrates how her skillset can be complementary to our native mass spectrometry approach and can contribute to further developing our drug discovery platform.”
    Sarah Teichmann, Member of the Scientific Advisory Board of OMass Therapeutics, added: “I am thrilled to be joining OMass Therapeutics’ SAB.